BRAF V600 MUTATION
Clinical trials for BRAF V600 MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRAF V600 MUTATION trials appear
Sign up with your email to follow new studies for BRAF V600 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis study tests an experimental oral drug, S241656, in adults with advanced cancers that have certain gene changes (like KRAS or BRAF mutations). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug can shrink tumors. About …
Matched conditions: BRAF V600 MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New trial aims to stop melanoma return after surgery
Disease control Recruiting nowThis study is for people with advanced melanoma (stage III or IV) that has a BRAF V600 mutation. Participants first receive a combination of two targeted drugs (encorafenib and binimetinib) before surgery. After surgery, doctors check how much the tumor has responded. Based on th…
Matched conditions: BRAF V600 MUTATION
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 01, 2026 15:57 UTC